Authors:
JELLIFFE RW
SCHUMITZKY A
BAYARD D
MILMAN M
VANGUILDER M
WANG X
JIANG F
BARBAUT X
MAIRE P
Citation: Rw. Jelliffe et al., MODEL-BASED, GOAL-ORIENTED, INDIVIDUALIZED DRUG-THERAPY - LINKAGE OF POPULATION MODELING NEW MULTIPLE MODEL DOSAGE DESIGN, BAYESIAN FEEDBACK AND INDIVIDUALIZED TARGET GOALS, Clinical pharmacokinetics, 34(1), 1998, pp. 57-77
Authors:
SPITZ F
DEMIGNON J
PORTEU A
KAHN A
CONCORDET JP
DAEGELEN D
MAIRE P
Citation: F. Spitz et al., EXPRESSION OF MYOGENIN DURING EMBRYOGENESIS IS CONTROLLED BY SIX SINEOCULIS HOMEOPROTEINS THROUGH A CONSERVED MEF3 BINDING-SITE/, Proceedings of the National Academy of Sciences of the United Statesof America, 95(24), 1998, pp. 14220-14225
Authors:
SPITZ F
DEVASCONCELOS ZA
CHATELET F
DEMIGNON J
KAHN A
MIRA JC
MAIRE P
DAEGELEN D
Citation: F. Spitz et al., PROXIMAL SEQUENCES OF THE ALDOLASE-A FAST MUSCLE-SPECIFIC PROMOTER DIRECT NERVE-DEPENDENT AND ACTIVITY-DEPENDENT EXPRESSION IN TRANSGENIC MICE, The Journal of biological chemistry, 273(24), 1998, pp. 14975-14981
Authors:
SPITZ F
DEMIGNON J
DEMEURIE J
SABOURIN JC
KAHN A
DAEGELEN D
MAIRE P
Citation: F. Spitz et al., A BINDING-SITE FOR NUCLEAR RECEPTORS IS REQUIRED FOR THE DIFFERENTIALEXPRESSION OF THE ALDOLASE-A FAST-TWITCH MUSCLE PROMOTER IN BODY AND HEAD MUSCLES, The Journal of biological chemistry, 273(1), 1998, pp. 561-567
Citation: P. Maire et F. Spitz, ROLE OF MYF5, MYOD AND PAX3 IN THE FORMATION OF HEAD, LIMB AND TRUNK MUSCLES, MS. Medecine sciences, 13(10), 1997, pp. 1182-1186
Authors:
SPITZ F
SALMINEN M
DEMIGNON J
KAHN A
DAEGELEN D
MAIRE P
Citation: F. Spitz et al., A COMBINATION OF MEF3 AND NFI PROTEINS ACTIVATES TRANSCRIPTION IN A SUBSET OF FAST-TWITCH MUSCLES, Molecular and cellular biology, 17(2), 1997, pp. 656-666
Authors:
CORVAISIER S
BLEYZAC N
CONFESSON MA
BUREAU C
MAIRE P
Citation: S. Corvaisier et al., A POPULATION-MODEL FOR AMIKACIN IN NON-IN SULIN-DEPENDENT DIABETIC-PATIENTS USING THE NON PARAMETRIC SOFTWARE NPEM2 (VOL 52, PG 219, 1997), Therapie, 52(5), 1997, pp. 515-515
Authors:
CORVAISIER S
BLEYZAC N
CONFESSON MA
BUREAU C
MAIRE P
Citation: S. Corvaisier et al., A POPULATION-MODEL FOR AMIKACIN IN NON-IN SULIN-DEPENDENT DIABETIC-PATIENTS USING THE NONPARAMETRIC SOFTWARE NPEM2, Therapie, 52(3), 1997, pp. 219-226
Authors:
ALBRAND G
CORVAISIER S
BISSARDON I
BLEYZAC N
MAIRE P
Citation: G. Albrand et al., METABOLIC COMPLICATIONS IN TUBERCULOSIS PATIENTS - THE DISEASE OR THETREATMENT, Journal of the American Geriatrics Society, 45(5), 1997, pp. 658-659
Authors:
PIVODUMAREST C
DEWEERDT C
TRONCY J
SORENSEN P
ROUX D
MAIRE P
Citation: C. Pivodumarest et al., POPULATION PHARMACOKINETIC MODELING OF AM INOKACIN IN NEUTROPENIC PATIENTS, Pathologie et biologie, 44(4), 1996, pp. 299-305
Authors:
SALMINEN M
LOPEZ S
MAIRE P
KAHN A
DAEGELEN D
Citation: M. Salminen et al., FAST-MUSCLE-SPECIFIC DNA-PROTEIN INTERACTIONS OCCURRING IN-VIVO AT THE HUMAN ALDOLASE-A M-PROMOTER ARE NECESSARY FOR CORRECT PROMOTER ACTIVITY IN TRANSGENIC MICE, Molecular and cellular biology, 16(1), 1996, pp. 76-85
Authors:
BREANT V
CHARPIAT B
SAB JM
MAIRE P
JELLIFFE RW
Citation: V. Breant et al., HOW MANY PATIENTS AND BLOOD-LEVELS ARE NECESSARY FOR POPULATION PHARMACOKINETIC ANALYSIS - A STUDY OF A 1-COMPARTMENT MODEL APPLIED TO CYCLOSPORINE, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 283-288
Authors:
SEMENZA GL
JIANG BH
LEUNG SW
PASSANTINO R
CONCORDET JP
MAIRE P
GIALLONGO A
Citation: Gl. Semenza et al., HYPOXIA RESPONSE ELEMENTS IN THE ALDOLASE-A, ENOLASE-1, AND LACTATE-DEHYDROGENASE-A GENE PROMOTERS CONTAIN ESSENTIAL BINDING-SITES FOR HYPOXIA-INDUCIBLE FACTOR-1, The Journal of biological chemistry, 271(51), 1996, pp. 32529-32537
Authors:
SALMINEN M
SPITZ F
FISZMAN MY
DEMIGNON J
KAHN A
DAEGELEN D
MAIRE P
Citation: M. Salminen et al., MYOTUBE-SPECIFIC ACTIVITY OF THE HUMAN ALDOLASE A M-PROMOTER REQUIRESAN OVERLAPPING BINDING-SITE FOR NF1 AND MEF2 FACTORS IN ADDITION TO ABINDING-SITE (M1) FOR UNKNOWN PROTEINS, Journal of Molecular Biology, 253(1), 1995, pp. 17-31
Authors:
SALMINEN M
MAIRE P
CONCORDET JP
KAHN A
DAEGELEN D
Citation: M. Salminen et al., FAST MUSCLE-SPECIFIC AND POSITION-INDEPENDENT EXPRESSION OF HUMAN ALDOLASE A TRANSGENES, Journal of cellular biochemistry, 1994, pp. 504-504
Authors:
SALMINEN M
MAIRE P
CONCORDET JP
MOCH C
PORTEU A
KAHN A
DAEGELEN D
Citation: M. Salminen et al., FAST-MUSCLE-SPECIFIC EXPRESSION OF HUMAN ALDOLASE-A TRANSGENES, Molecular and cellular biology, 14(10), 1994, pp. 6797-6808
Authors:
CHARPIAT B
BREANT V
PIVOTDUMAREST C
MAIRE P
JELLIFFE R
Citation: B. Charpiat et al., PREDICTION OF FUTURE SERUM CONCENTRATIONS WITH BAYESIAN FITTED PHARMACOKINETIC MODELS - RESULTS WITH DATA COLLECTED BY NURSES VERSUS TRAINED PHARMACY RESIDENTS, Therapeutic drug monitoring, 16(2), 1994, pp. 166-173
Authors:
CONFESSON MA
BARBAUT X
MAIRE P
VERGNAUD JM
ELBROUZI A
JELLIFFE RW
Citation: Ma. Confesson et al., COMPUTED AMINOGLYCOSIDE CONCENTRATIONS IN ENDOCARDIAL VEGETATIONS - RELATIONS WITH CLINICAL-PRACTICE DURING INFECTIOUS ENDOCARDITIS, EXAMPLE OF AMIKACIN, Therapie, 49(1), 1994, pp. 27-34
Authors:
JELLIFFE RW
MAIRE P
SATTLER F
GOMIS P
TAHANI B
Citation: Rw. Jelliffe et al., ADAPTIVE-CONTROL OF DRUG-DOSAGE REGIMENS - BASIC FOUNDATIONS, RELEVANT ISSUES, AND CLINICAL EXAMPLES, International journal of bio-medical computing, 36(1-2), 1994, pp. 1-23
Authors:
MAIRE P
BARBAUT X
VERGNAUD JM
ELBROUZI M
CONFESSON MA
PIVOT C
CHUZEVILLE M
IVANOFF N
BRAZIER JL
JELLIFFE RW
Citation: P. Maire et al., COMPUTATION OF DRUG CONCENTRATIONS IN ENDOCARDIAL VEGETATIONS IN PATIENTS DURING ANTIBIOTIC-THERAPY, International journal of bio-medical computing, 36(1-2), 1994, pp. 77-85
Citation: R. Jelliffe et al., MEDINFO92 SATELLITE OPEN CONFERENCE ON ESTIMATION AND CONTROL OF PATIENT VARIABILITY FOR INDIVIDUALIZED ANTIBIOTIC-THERAPY - FOREWORD, International journal of bio-medical computing, 36(1-2), 1994, pp. 180000011-180000012
Authors:
JELLIFFE R
LAFFONT A
BARBAUT X
GIRARD P
CHAPELLE G
POBEL C
BEROD T
PIVOT C
LACARELLE B
DEBORD J
BOISSEL J
MAIRE P
Citation: R. Jelliffe et al., PHARMACOKINETICS OF AMIKACIN IN A LARGE POPULATION USING THE NPEM ALGORITHM, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 160-160
Authors:
POYNARD T
ABADIA R
ABBAS A
ABENSUR R
ALLE JP
ALLEMOZ D
AMAR I
AMERIEN G
AMSELLEM A
ARRAMONTUCOO D
ARZUL C
AUBERT H
AUCOMTE A
AUDEGON G
AUFFRET Y
AZZI A
BADETTI J
BAGNOULS G
BANDU M
BASIN N
BERCK C
BECQWORT JP
BEGUE JY
BENGUALID J
BENHAIM S
BERAUD G
BILLARD JL
BLIME JP
BOEHM C
BONIN N
BOTTOS JP
BOUCHER AM
BOULENGER F
BOUQUET JP
BOYER JD
BRAJER S
BREBAN P
BREDOUX P
BRODSCHII F
BURGUIERE P
BUTEL J
CALVET B
CAMBRAY S
CANARD JM
CAUSSE JL
CAZALS JB
CERF G
CHANTELOUP JM
CHAPALAIN JC
CHARBIT M
CHAUVEINC L
CHIESA A
COLONNA P
COLSON M
COMUCE C
CONGRAD P
CONSIGNY P
COOMANS D
COTINAT M
COTTEN JC
COUDERT P
COULANJON G
COULOM P
COURTIAL P
CUTURELLO L
DANTIN B
DECROIX B
DELETTE O
DELTOMBE B
DIACONO M
DIAZ J
DUREAU A
DUDICOURT JC
DUPERIE J
DUPINNIZARD B
DUPONT T
DURY P
EDOUARD R
ELHAIK E
ELOUARDBLANC L
ESTABLE P
FIGAROLBOUTIN MF
FORTAS L
FORTIER B
FOUCARD M
FOURGUETTE E
FEMOND L
GABRIELE R
GABRIELLINI F
GALTIE G
GAUSSEN JM
GAUTIER JM
GOBERT F
GOLDFAIN D
GOMEZ H
GRANGE M
GRUNBERG B
HALPERIN S
HERBET T
HILPERT G
HOUDEE G
JACQUES JP
JONAS C
JULIEN PE
JULIEN H
JUTEL P
KAFFY L
KALT P
KARSENTY C
KHERROUBI H
KIRIAKOS A
KOLOPP JL
LAMIRAUD B
LAPLANE B
LAREDO JC
LARRUE P
LAUGROS A
LAURENT P
LEBAYON A
LEBIHAN P
LECOUTEULX C
LETEXIER A
LETORTU R
LECLERC P
LEDUC JL
LEFEVRE R
LELONG P
LEMARCHAND N
LEMEE P
ANTOINE L
LEURENT B
LHERMIE M
LOISON P
LOMBARDO G
LOMBART J
LOTH F
LOUBIERE M
LOYER R
LUCIANI F
LUNAUD B
MACHEREY D
MAGEN M
MAGOIS JY
MAHE M
MAIRE P
MAJEAU JM
MANIERE A
MARCHETTI B
MARGULIES A
MAROIS F
GEORGE M
MASBOU P
MASSABIE B
MATTEI A
MERLIN P
MESSERSCHMITT C
MIR WS
MONGES B
MOURRUT C
NAVARRO P
NAYRAC A
NEUMEIER M
NGUYEN PT
NIZARD G
NOIZET JM
NOUN K
NURY B
OLLIVIER B
PARIENTE E
PARIS Y
PARMENTIER T
PAROIS L
PAUTRAT JM
PAUWELS B
PECRIAUX O
PELLAT B
PEROUA JJ
PERRIGUEY M
PFLUMIO F
PICARD J
PLANTE M
PLIHON G
POMMELET P
PORTEFAIX JP
QUIVIGER JF
RAIMBERT P
RAPOPORT G
RAYNAL JN
RESENSBERG M
REIG JJ
RENAULT G
REVOL C
RICHARD M
RICHARD P
RIERA JC
RION JL
ROBLIN X
ROGIER P
ROTENBERG A
ROUSSY P
ROUX M
RUMEAU JM
SALVATORI G
SANCHEZ JY
SAURFELT MM
SCHLOSSERG P
SCHMITZ D
SCOTTO JM
SENG G
SERVENT L
SIMON JF
SOUILE JM
SPREUX T
TAOUBI N
TESTE Y
TRAISSAC JP
TUBIANA B
TUBIANA GE
VANDRO P
VEBER P
VEDEL JP
VENOT J
VERMEULEN L
VERNEAU A
VERNISSE B
VEYRES B
VIAUD S
VIELH J
VILLAND J
VILLARD J
VITAUX J
WALLEZ JY
WANTIER M
WEBER JE
ZARKA A
Citation: T. Poynard et al., RELAPSE RATE OF PATIENTS AFTER HEALING OF ESOPHAGITIS - A PROSPECTIVE-STUDY OF ALGINATE AS SELF-CARE TREATMENT FOR 6 MONTHS, Alimentary pharmacology & therapeutics, 7(4), 1993, pp. 385-392